Augusto Villegas
机构:BC Children's Hospital · ORCID:0009-0009-6332-3441
发表论文 57 篇 · 总被引 8979 次 · h-index 15
代表论文
- Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC (2019 · Journal of Thoracic Oncology · 被引 436)
- Outcomes with durvalumab by tumour PD-L1 expression in unresectable, stage III non-small-cell lung cancer in the PACIFIC trial (2020 · Annals of Oncology · 被引 227)
- Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study (2019 · The Lancet Oncology · 被引 192)
- Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non–Small–Cell Lung Cancer (PACIFIC) (2021 · Clinical Lung Cancer · 被引 57)
- Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC) (2020 · Lung Cancer · 被引 50)
- Outcomes with durvalumab after chemoradiotherapy in stage IIIA-N2 non-small-cell lung cancer: an exploratory analysis from the PACIFIC trial (2022 · ESMO Open · 被引 25)